Hereβs Why TCW Relative Value Large Cap Fund Added AMETEK Inc (AME) to Its Portfolio
π TCW Relative Value Large Cap Fund added AMETEK Inc. (AME) as a newly acquired position in its fourth-quarter 2025 investor letter.
π The fund returned 4.29% in Q4 2025, outperforming the Russell 1000 Value Index by 0.48 percentage points.
π AMETEK stock closed at $218.42 per share on April 6, 2026, with a year-to-date gain of 44.26%.
π° The company holds a market capitalization of approximately $50.03 billion and operates as an industrial technology firm.
π AMETEK's revenue is split between the Electromechanical Group (EMG) at 33% and Electronic Instruments Group (EIG) at 67%.
βοΈ EMG focuses on precision motion controls, medical devices, heat exchangers, and interconnects for aerospace and industrial verticals.
π¬ EIG provides test and measurement products for power, process, and aerospace market segments.
π‘ The investment catalyst for AMETEK includes new product introductions, market expansion, and cost-cutting restructuring efforts.
β‘ The company's asset-light business model generates strong and consistent cash flow with an organic sales contribution of ~26% from the past three years.
π€ AMETEK employs a Growth Model flywheel through niche acquisitions and lean manufacturing tools to improve profitability and ROE.
π Hedge fund interest in AMETEK increased slightly to 64 portfolios holding shares at the end of Q4 2025, up from 58 previously.
β οΈ TCW notes that while acknowledging AMETEK's potential, certain AI stocks currently offer greater upside potential with lower downside risk.
π The article references previous coverage linking AMETEK to best diversified dividend stocks and hedge fund investor letters.
π° This analysis was published by Insider Monkey regarding the fund's fourth-quarter 2025 allocation decisions.
- TCW Relative Value Large Cap Fund added AMETEK Inc (AME) to its portfolio, highlighting it as a newly acquired position.
- AMETEK shares gained 44.26% over the last twelve months, demonstrating strong performance despite a recent one-month dip of -3.48%.
- The company reported significant upside in revenue, with 26% of sales derived from products released in the past three years, showcasing successful growth model execution.
- AMETEK maintains an asset-light business model that drives strong and consistent cash flow generation.
- The company has expanded into niche markets through its Growth Model, capturing secular growth trends across aerospace, defense, medical, and automation verticals.
- Operational Excellence strategy deploys lean manufacturing tools to improve profitability of acquired companies, supporting margin expansion over the medium term.
- Hedge fund interest is increasing with 64 portfolios holding AMETEK at end of fourth quarter 2025, up from 58 in the previous quarter.
- AMETEK's ROE and margins are expected to improve meaningfully as it refines its Growth Model flywheel and advances continuous operational improvement activities.
- AMETEK's stock closed down -3.48% in the last month, indicating recent downward momentum despite strong long-term performance.
- The fund manager explicitly states that AMETEK is not on the list of their top 40 most popular stocks, suggesting it may not be a primary holding.
- There are concerns about AMETEK's valuation compared to AI stocks, with the fund belief that certain AI stocks offer greater upside potential and carry less downside risk.
- The investment thesis relies heavily on future initiatives like new products/markets and cost cutting/restructuring, which introduces execution risk if these catalysts do not materialize as expected.
- Only 64 hedge fund portfolios held AMETEK at the end of Q4 2025, which could indicate limited institutional consensus compared to more favored peers.